Aller au contenu principal
Profil bibliographique

Kateryna Viligorska

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

38Publications signalées
50Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Cystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) ResearchNeonatal Respiratory Health ResearchRespiratory and Cough-Related ResearchHuman Health and Disease

Les publications récentes

Accès ouvert 2026 article OpenAlex

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis

Michal Shteinberg, Charles Haworth, Jennifer Pollock, Shai Cohen et autres

Introduction: Chronic rhinosinusitis (CRS) is a common comorbidity in bronchiectasis. Previous studies suggested that bronchiectasis with CRS is associated with elevated type 2 biomarkers, representing an "eosinophilic bronchiectasis" phenotype. However, whether the association with type 2 inflammation exists in rare aetiologies of …

il, gb, gr, it, de, es, fr, se, fi, rs, pl, md, pt, be (code pays fourni par la source)

0 citations ERJ Open Research
Accès ouvert 2026 article OpenAlex

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries

Rebecca C Hull, Yang Liu, Zu Cao, Kathryna Tan Li Xuan et autres

BACKGROUND: Bronchiectasis and diabetes commonly coexist and are associated with immune dysfunction and increased susceptibility to infection. Although diabetes is associated with worse prognosis in cystic fibrosis-related bronchiectasis, data are scarce for its impact on non-cystic fibrosis bronchiectasis. This study aimed to …

gb, cn, kr, sg, fr, es, in, be, il, de, gr, ie, it, au (code pays fourni par la source)

3 citations The Lancet Respiratory Medicine
Accès ouvert 2026 article OpenAlex

In vitro diagnostics for respiratory infections: current state and opportunities

Ana Catalina Hernandez Padilla, Kateryna Viligorska, Juan Pablo Rodriguez Ruiz, Letizia Traversi et autres

Acute respiratory tract infections represent a significant burden in primary care, with antibiotics often prescribed unnecessarily. This contributes to the escalating threat of antimicrobial resistance (AMR) by increasing the burden of infectious diseases and mortality risk. This is a report from a …

fr, gb, be, es, it (code pays fourni par la source)

0 citations Breathe
Accès ouvert 2026 preprint OpenAlex

Upper airway ciliary dysfunction in bronchiectasis: The EMBARC cilia cohort study

M Bottier, Erin Cant, Lidia Gómez Perea, Morven K Shuttleworth et autres

Abstract Mucociliary clearance is a key component of the pathophysiology of bronchiectasis but cilia function is poorly defined. This study aims to characterize nasal ciliary function in bronchiectasis and examine associations with disease severity, infection, inflammation and outcome. Adults with bronchiectasis and …

gb, us, es, Égypte, it, be, nl, il (code pays fourni par la source)

0 citations medRxiv
Accès ouvert 2025 article OpenAlex

Neutrophil proteomics in respiratory viral infection

Kateryna Viligorska

INNOVATE was a prospective observational cohort study of hospitalized patients admitted to Ninewells Hospital, Dundee, United Kingdom. INNOVATE recruited hospitalized patients between December 2022 and March 2023. Patients were recruited upon admission with PCR virus positive test for influenza, SARS-CoV-2 or other …

gb (code pays fourni par la source)

0 citations Discovery Research Portal (University of Dundee)
2025 conference-paper OpenAlex

T6 Genetic characterisation of pseudomonas aeruginosa isolates from bronchiectasis patients in a randomized, double-blind placebo-controlled trial of a bispecific monoclonal antibody targeting Psl and PcrV (GREAT-2)

RC Hull, M.B. Long, Amy Gilmour, I.D. Petrou et autres

Introduction Pseudomonas aeruginosa (PA) airway infections in bronchiectasis are associated with increased disease severity and exacerbations. New treatment options are needed due to inconsistent results with inhaled antibiotics and increasing concerns over antimicrobial resistance. The GREAT-2 trial of gremubamab, a bispecific monoclonal …

gb, it, es, fi, nl (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

Exploring the neutrophil proteome in influenza and COVID-19: results from the INNOVATE study

Kateryna Viligorska, Jeffrey T.-J. Huang, Holly Lind, Kara Robertson et autres

Introduction: Studies exploring the neutrophil proteome in COVID-19 showed a key role for neutrophils in viral infection, with changes during acute infection linked to disease severity and outcomes. Data on neutrophil proteome is lacking in other viral infections. Understanding neutrophil proteomic and …

gb (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

Airway epithelial integrity in bronchiectasis (BE): Preliminary data from the BRILLIANT study

Erin Cant, Morven K. Shuttleworth, Emma Johnson, Thomas Pembridge et autres

Introduction: In BE dysfunction of the respiratory epithelium contributes to disease pathogenesis and may represent a target for therapy. Few studies have characterized the lower airway epithelium in BE. Methods: This prospective observational study conducted in-depth characterisation of the epithelium in BE …

gb, sg, ch, es, fi (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

Characterising systemic inflammation in patients with bronchiectasis: data from the EMBARC BRIDGE study

Chloe Hughes, B Long Merete, Kateryna Viligorska, Jamie Stobo et autres

Introduction: Bronchiectasis is a systemic inflammatory disease with a proposed role for neutrophils in disease pathogenesis. The mechanisms leading to systemic inflammation are not well understood. Methods: Multi-centre, international observational study of patients with stable bronchiectasis (BRIDGE study; NCT03791086 ). Patients were …

gb, be, il, it, nl, es, de, gr, pt, ie (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

Characterising adult Primary ciliary dyskinesia (PCD) in the EMBARC-BRIDGE cohort

Amelia Shoemark, Holly Lind, Kateryna Viligorska, Pieter Goeminne et autres

PCD is an inherited cause of bronchiectasis. EMBARC-BRIDGE is a translational research substudy embedded within the European Bronchiectasis Registry. We compare patients with PCD in EMBARC BRIDGE to bronchiectasis of other causes. Adults with bronchiectasis were recruited to an observational cohort study …

gb, be, il, it, nl, es, de, gr, pt, ie (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

Rhinosinusitis with nasal polyposis is a clinical predictor of type 2 inflammation in bronchiectasis: an EMBARC registry analysis

Michal Shteinberg, Charles Haworth, Jennifer Polliock, Shai Cohen et autres

Introduction: Chronic rhinosinusitis (CRS) and nasal polyposis (NP) are common comorbidities in bronchiectasis. We aimed to assess the prevalence, impact, and association of CRS and NP with type 2 inflammatory biomarkers in people with bronchiectasis. Methods: Using the EMBARC bronchiectasis registry, we …

il, gb, gr, it, de, es, fr, se, fi, rs, md, ir, ge, pt, be, nl (code pays fourni par la source)

0 citations
2025 conference-abstract OpenAlex

A bispecific monoclonal antibody targeting Pseudomonas aeruginosa in bronchiectasis: results from the GREAT-2 trial

Merete Bridget Long, Rebecca C Hull, Amy Gilmour, Kateryna Viligorska et autres

Rationale: We report a randomized, double-blind, placebo-controlled trial of gremubamab, a bispecific mAb targeting Psl exopolysaccharide and PcrV T3SS component, in people with bronchiectasis and P. aeruginosa infection. Methods: Patients were randomised 1:1:1 to 1500mg or 500mg gremubamab IV infusion, or placebo, …

gb, it, us, es, fr, nl, fi (code pays fourni par la source)

1 citation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.